Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huanglian Shangqing Pill is an approved traditional Chinese medicine (TCM) formulation developed and manufactured by Shandong Wohua Pharmaceutical Co., Ltd. It is designed to clear heat, dispel wind, and alleviate pain, specifically targeting 'wind-heat' in the upper body. Clinical indications include headache, vertigo, toothache, sore throat, painful or swollen gums, ear-ache, tinnitus, and congestive conjunctivitis. Additionally, it is used to treat systemic symptoms of internal heat such as constipation and dark urine. The formulation is a complex herbal mixture, typically containing berberine hydrochloride as an active constituent, and is administered orally as a pill.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huanglian shangqing pill.